GreenLight Biosciences Holdings, PBC, trading under the ticker ENVI, represents a de-SPAC combination between Environmental Investment Corporation, a blank-check company that completed its initial public offering in 2020, and GreenLight Biosciences, an RNA biology firm developing products across agricultural bioprotection and human health. The 8-K filed January 20, 2021 relates to the business combination transaction that brought GreenLight Biosciences onto public markets. GreenLight's RNA manufacturing platform underpinned both crop-protection biologics and mRNA-based therapeutic and vaccine programs, placing the combined entity firmly in the life sciences sector. For comprehensive sponsor details, deal timelines, and filing analytics on ENVI and hundreds of other SPAC transactions, sign up for full data access at SpacDesk.